SHLT (SHL Telemedicine, Ltd.) סך נכסים נקיים

This chart shows the market price of SHL Telemedicine Ltd. (SHLT) at 0.07. SHL Telemedicine Ltd. (SHLT) minimizes risks by providing remote cardiac monitoring services in Israel and Europe. Revenues are based on the perpetual use of proprietary sensors, which guarantee regular insurance reimbursements. Stringent certification requirements and patent protection create a robust defensive barrier, limiting the expansion of new players within the conservative cardiology environment.

Book value capitalization reflects the real value of a company's net equity, serving as a fundamental filter against market speculation and asset overvaluation. For SHL Telemedicine Ltd. (SHLT), with its high user loyalty and support from US regulators, the trend in book value of equity confirms business resilience; its growth ensures that the expansion into telemedicine is backed by real assets rather than solely by trader optimism.